The modulating effect of PSC833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia

被引:22
作者
den Boer, ML
Pieters, R
Kazemier, KM
Janka-Schaub, GE
Henze, G
Veerman, AJP
机构
[1] Free Univ Amsterdam Hosp, Dept Pediat Hematol Oncol, NL-1007 MB Amsterdam, Netherlands
[2] COALL Study Grp, Hamburg, Germany
[3] ALL REZ BFM Grp, Berlin, Germany
关键词
drug resistance; PSC833; cyclosporin A; verapamil; genistein; P-glycoprotein; MRP; LRP;
D O I
10.1038/sj.leu.2401035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Resistance to anthracyclines is related to a poor prognosis in childhood acute lymphoblastic leukemia (ALL). Resistance to this class of drugs may (partly) be reversed by modulating agents, as has been demonstrated in a variety of cell lines. However, it is unknown which modulators may be of clinical benefit in childhood ALL. Therefore, we studied the modulating effect of PSC 833, cyclosporin A (CsA), verapamil (Vp) and genistein on daunorubicin (DNR) cytotoxicity, accumulation and retention in childhood ALL cells, DNR cytotoxicity was determined using the MTT assay; DNR accumulation, DNR retention and the expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and major vault protein/lung resistance protein (LRP) were determined by flow cytometry. In the majority of samples PSC 833 (19/26), CsA (22/26) and Vp (15/18) sensitized the cells to DNR whereas genistein made 25 out of 26 samples more resistant to DNR. The sensitizing effect on the cytotoxicity of DNR was median 1.2-fold using 2 mu M PSC 833 (P=0.025), 1.5-fold using 4 mu M CsA (P=0.003) and 1.6-fold using 6 mu M Vp (P=0.012) whereas the adverse effect of 25 mu M genistein was median 1.8-fold (P<0.0001). No relationship was found between the sensitizing effect of PSC 833, CsA or Vp and the degree of DNR resistance. In contrast, the adverse effect of genistein was largest in DNR sensitive samples (P=0.003). The effect of each modulator on the cytotoxicity of DNR did not differ between initial and relapse ALL samples although the latter were median 1.4-fold more resistant to DNR (P=0.005). Modulation of DNR cytotoxicity was not correlated with changes in the accumulated and retained intracellular DNR content or with the expression of P-gp, MRP and LRP. Besides genistein, PSC 833, CsA and Vp incidentally made ALL cells more resistant to DNR. CsA stimulated the leukemic cell survival in seven out of 26 samples, a phenomenon that was not related to the degree of DNR resistance. In conclusion, PSC 833, CsA and Vp but not genistein may be used to sensitize cells to DNR in childhood ALL. The data also indicate that not all patients may have a therapeutic benefit from these modulators. Therefore, an in vitro culture assay may be necessary to screen for patients who may benefit by a modulator in their therapy.
引用
收藏
页码:912 / 920
页数:9
相关论文
共 57 条
[1]   CHEMOSENSITISATION OF SPONTANEOUS MULTIDRUG-RESISTANCE BY A 1,4-DIHYDROPYRIDINE ANALOG AND VERAPAMIL IN HUMAN GLIOMA CELL-LINES OVEREXPRESSING MRP OR MDR1 [J].
ABE, T ;
KOIKE, K ;
OHGA, T ;
KUBO, T ;
WADA, M ;
KOHNO, K ;
MORI, T ;
HIDAKA, K ;
KUWANO, M .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :418-423
[2]  
BAILLY JD, 1995, LEUKEMIA, V9, P799
[3]   CHEMOSENSITISATION AND DRUG ACCUMULATION EFFECTS OF CYCLOSPORINE-A, PSC-833 AND VERAPAMIL IN HUMAN MDR LARGE CELL LUNG-CANCER CELLS EXPRESSING A 190K MEMBRANE-PROTEIN DISTINCT FROM P-GLYCOPROTEIN [J].
BARRAND, MA ;
RHODES, T ;
CENTER, MS ;
TWENTYMAN, PR .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) :408-415
[4]   EXPRESSION OF MDR1, MRP, TOPOISOMERASE-II-ALPHA/BETA, AND CYCLIN-A IN PRIMARY OR RELAPSED STATES OF ACUTE LYMPHOBLASTIC LEUKEMIAS [J].
BECK, J ;
HANDGRETINGER, R ;
DOPFER, R ;
KLINGEBIEL, T ;
NIETHAMMER, D ;
GEKELER, V .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) :356-363
[5]   Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer [J].
Boote, DJ ;
Dennis, IF ;
Twentyman, PR ;
Osborne, RJ ;
Laburte, C ;
Hensel, S ;
Smyth, JF ;
Brampton, MH ;
Bleehen, NM .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :610-618
[6]   Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity [J].
Broxterman, HJ ;
Sonneveld, P ;
Feller, N ;
Ossenkoppele, GJ ;
Wahrer, DCR ;
Eekman, CA ;
Schoester, M ;
Lankelma, J ;
Pinedo, HM ;
Lowenberg, B ;
Schuurhuis, GJ .
BLOOD, 1996, 87 (11) :4809-4816
[7]  
CHUGANI DC, 1993, J CELL SCI, V106, P23
[8]   Relationship between major vault protein lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia [J].
den Boer, ML ;
Pieters, R ;
Kazemier, KM ;
Rottier, MMA ;
Zwaan, CM ;
Kaspers, GJL ;
Janka-Schaub, G ;
Henze, G ;
Creutzig, U ;
Scheper, RJ ;
Veerman, AJP .
BLOOD, 1998, 91 (06) :2092-2098
[9]   Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia [J].
denBoer, ML ;
Zwaan, CM ;
Pieters, R ;
Kazemier, KM ;
Rottier, MMA ;
Flens, MJ ;
Scheper, RJ ;
Veerman, AJP .
LEUKEMIA, 1997, 11 (07) :1078-1085
[10]  
DENBOER ML, UNPUB RELATIONSHIP I